McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin Noonan is quoted in a July 8, 2014 online Nature article entitled, “Biotech reels over patent ruling.” Guidelines that forbid patents on a wide array of natural products, phenomena and principles have many in the biotechnology and pharmaceutical industries worried about the future of their business. View the article
